Assessing the Impact of Menstrual Cycle in Incidence of Symptoms of Patients with Multiple Sclerosis

Document Type : Original Article (s)

Authors

1 Professor, Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Associate Professor, Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Assistant Professor, Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Multiple sclerosis (MS) is an autoimmune disease that is associated with demyelination of the neurons axon in the central nervous system. The predominant age range of this disease is related to adolescence and its prevalence rate in women is two to three times more than in men. Indentifyingthe factors and conditions cause diseases recurrence and in other words providing disease conditions can be effective in the prevention of diseases occurrence or recurrence. One of these conditions and requirements is menstrual cycle of women and hormonal changes that can be effective on the occurrence or recurrence of the disease and therefore indentifying the relationship between hormonal changes during menstruation seem necessary for the disease recurrence.Methods: In this study, 196 women with MS, who had regular menstrual cycle had referred due todisease attack, were studied in terms of the time of occurring the attack in menstrual cycle. Menstrual cycle of the patients was divided into three phases based on the estrogen and progesterone levels. The first phase is three days after onset of menstrual cycle until the time of ovulation and is simultaneous with increased estrogen. The second phase is since probable ovulation time (Approximately 14th day in a 28-day cycle or 14 days before the period in the other cycles) until three days before onset of the next menstruation; in this phase, the levels of both estrogen and progesterone increase. The third phase is equal to three days before bleeding until three days after the onset (decreased estrogen and progesterone levels). According to the LMP date of patients and time of attack, the phase of attack occurrence in menstrual cycle was determined for each of them.Findings: The highest recurrence rate of attack (99 attacks which was equal to 50.6% of the total attacks) occurred at the third phase of menstrual cycle in which the levels of both estrogen and progesterone was low. Twenty-seven percent of the attacks recurrence occurred at the first phase (which the estrogen level is high) and 22.4 percent of the attacks recurrence occurred at the second phase (which both estrogen and progesterone levels are high) that the results showed no significantdifference.Conclusion: The disease might be influenced by the female sex hormones and sex steroids can alter the disease activity. Estrogen may play a protective role in the disease and reduce estrogen is associated with increased recurrence of attacks.

Keywords


  1. McGuinness SD, Peters S. The diagnosis of multiple sclerosis: Peplau's Interpersonal Relations Model in practice. Rehabil Nurs 1999; 24(1): 30-3.
  2. Grossman RI, Yousem DM. Neuroradiology: The Requisites. 2nd ed. Louis, Missouri: Mosby; 2003.
  3. Frohman EM, Racke MK, Raine CS. Multiple sclerosis--the plaque and its pathogenesis. N Engl J Med 2006; 354(9): 942-55.
  4. Martin R, McFarland HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995; 32(2): 121-82.
  5. Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006; 5(11): 932-6.
  6. Duquette P, Girard M. Hormonal factors in susceptibility to multiple sclerosis. Curr Opin Neurol Neurosurg 1993; 6(2): 195-201.
  7. Ostensen M, Aune B, Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 1983; 12(2): 69-72.
  8. Hutchinson M. Pregnancy in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993; 56(10): 1043-5.
  9. Damek DM, Shuster EA. Pregnancy and multiple sclerosis. Mayo Clin Proc 1997; 72(10): 977-89.
  10. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998; 339(5): 285-91.
  11. Bernardi S, Grasso MG, Bertollini R, Orzi F, Fieschi C. The influence of pregnancy on relapses in multiple sclerosis: a cohort study. Acta Neurol Scand 1991; 84(5): 403-6.
  12. Correale J, Gilmore W, McMillan M, Li S, McCarthy K, Le T, et al. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J Immunol 1995; 154(6): 2959-68.
  13. Formby B. Immunologic response in pregnancy. Its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol Metab Clin North Am 1995; 24(1): 187-205.
  14. Faas M, Bouman A, Moesa H, Heineman MJ, de LL, Schuiling G. The immune response during the luteal phase of the ovarian cycle: a Th2-type response? Fertil Steril 2000; 74(5): 1008-13.
  15. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002; 52(4): 421-8.
  16. Smith R, Studd JW. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J R Soc Med 1992; 85(10): 612-3.
  17. Scott JR, Gibbs RS, Karlan BY, Haney AF. Danforth's Obstetrics and Gynecology (Obstetrics & Gynecology (Danforth's/ Scott)). 9th ed. Hagerstown, Maryland: Lippincott Williams & Wilkins; 2003.
  18. Zorgdrager A, De KJ. Menstrually related worsening of symptoms in multiple sclerosis. J Neurol Sci 1997; 149(1): 95-7.
  19. Zorgdrager A, De KJ. The premenstrual period and exacerbations in multiple sclerosis. Eur Neurol 2002; 48(4): 204-6.